Botulinum toxin below the eyes

International Ophthalmology Clinics

Volumn 45, Issue 3, 2005, Pages 133-141

  Carruthers, Jean ^a   Carruthers, Alastair ^a  

^a Carruthers Cosmetic Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

CHIN; FACE; FACE ASYMMETRY; HEMIFACIAL SPASM; HUMAN; INJECTION; LIP; MASSETER MUSCLE; MELOMENTAL FOLD; MENTAL CREASE; MOUTH; MOUTH FROWN; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; PALPEBRAL FISSURE; PATIENT SELECTION; PEAU D ORANGE CHIN; PERIORAL WRINKLE; PRIORITY JOURNAL; REJUVENATION; REVIEW; TECHNIQUE; WRINKLE;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACIAL MUSCLES; HUMANS; NEUROMUSCULAR AGENTS; REJUVENATION; SKIN AGING;

EID: 22544440005     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000167163.41127.e6     Document Type: Review

References (15)

1. Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg. 2003;112:6S-18S.
2. Borodic GE. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthal Plast Reconstr Surg. 1992;8:137.
3. Sposito MM. New indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg. 2003;112:76S-85S.
4. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg. 1999;103:701.
5. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg. 2001;20:71-84.
6. Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg. 2001;27:703-708.
7. Goldman MP. Festoon formation after infraorbital botulinum-A toxin: a case report. Dermatol Surg. 2003;29:560-561.
8. Carruthers J, Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg. 2003;29:468-476.
9. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21:1740-1747.
10. Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain. 2002;18(Suppl):S142- S146.
11. To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 2001;54:197-200.
12. von Lindern JJ, Niederhagen B, Appel T, et al. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscle: an alternative treatment. Plast Reconstr Surg. 2001;107:327-332.
13. Park MY, Ahn KY, Jung DS. Application of botulinum toxin A for treatment of facial contouring in the lower face. Dermatol Surg. 2003;29:477-483.
14. Kim HJ, Yum KW, Lee SS, et al. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg. 2003;29:484-489.
15. Klein AW. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29:549-556.